Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Company dna symphogen a slash s
no operation time available
210.56
1 office
active in Legal Services

Representative before the EPO

Technology company logo thumb
no operation time available
Technology Company

We have observed 12 EP applications Henrik Bendiksen has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 09, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12794878

POXVIRUS VECTOR FOR THE EXPRESSION OF BACTERIAL ANTIGENS LINKED TO TETANUS TOXIN FRAGMENT C

IPC classification:
A61K 39/02, C12N 15/86
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
PATENT GRANTED
EP13708667

AGONISTS AND ANTAGONISTS OF TOLL-LIKE RECEPTOR (TLR) 13

IPC classification:
A61K 31/7088, C12N 15/117, A61P 37/02, A61P 31/04
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
GRANT OF PATENT INTENDED
EP13730812

POXVIRAL VECTORS FOR LOW ANTIBODY RESPONSE AFTER A FIRST PRIMING IMMUNIZATION

IPC classification:
C12N 15/86
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
EXAMINATION IN PROGRESS
EP13717721

RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE

IPC classification:
A61K 39/155, C12Q 1/68
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
EXAMINATION REQUESTED
EP13717720

METHODS AND COMPOSITIONS FOR ENHANCING VACCINE IMMUNE RESPONSES

IPC classification:
A61K 39/12, A61K 39/00
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
GRANT OF PATENT INTENDED
EP13783852

PR13.5 PROMOTER FOR ROBUST T-CELL AND ANTIBODY RESPONSES

IPC classification:
A61K 39/00, C12N 15/863
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
GRANT OF PATENT INTENDED
EP14803277

COMBINATION THERAPY FOR TREATING CANCER WITH A POXVIRUS EXPRESSING A TUMOR ANTIGEN AND AN ANTAGONIST AND/OR AGONIST OF AN IMMUNE CHECKPOINT INHIBITOR

IPC classification:
A61K 39/00
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
EXAMINATION REQUESTED
EP14806215

COMPOSITIONS AND METHODS VECTORS FOR INDUCING AN ENHANCED IMMUNE RESPONSE USING POXVIRUS VECTORS

IPC classification:
C12N 15/86
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
EXAMINATION REQUESTED
EP15724454

COMBINATION THERAPY FOR TREATING CANCER WITH A POXVIRUS EXPRESSING A TUMOR ANTIGEN AND A MONOCLONAL ANTIBODY AGAINST TIM-3

IPC classification:
A61K 39/395, A61K 39/00
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
EXAMINATION REQUESTED
EP15766889

METHODS AND COMPOSITIONS FOR INTRA-NASAL IMMUNIZATION WITH RECOMBINANT MVA ENCODING FLAGELLIN

IPC classification:
A61K 39/00, C07K 14/255, A61K 39/39
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
Request for examination was made
EP16734206

RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) FOOT AND MOUTH DISEASE VIRUS (FMDV) VACCINE

IPC classification:
A61K 39/12
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
Request for examination was made
EP16775852

PROMOTERS FOR ENHANCING EXPRESSION IN POXVIRUSES

IPC classification:
C12Q 1/68
Applicant:
Bavarian Nordic A/S
Agent:
Henrik Bendiksen, Bavarian Nordic GmbH
Status:
Request for examination was made

Please Sign in to use this feature